To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DLGAP5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
328 supporting clones for gene DLGAP5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AB076695   DLGAP5.a 1 to 2979 1 to 2979 G69E tiling clone,   2979/2979
(100 %)
4 diff
(99.9 %id)
NM_014750.4   DLGAP5.a 1 to 2993 1 to 2993 exact RefSeq,   2993/2993
(100 %)
0 diff
(100 %id)
BC010658 Eye, retinoblastoma DLGAP5.a 109 to 2979 1 to 2871 exact tiling clone, available from MGC, AAA   2871/2871
(100 %)
0 diff
(100 %id)
AK291847   DLGAP5.a 124 to 2981 1 to 2858 P382L     2858/2858
(100 %)
1 diff
(100.0 %id)
D13633   DLGAP5.a 128 to 2979 1 to 2852 exact available from KIAA,   2852/2852
(100 %)
2 diff
(100.0 %id)
AU133356   DLGAP5.a 143 to 943 2 to 805   capped   804/804
(100 %)
6 diff
(99.3 %id)
AU116988 whole embryo, mainly head DLGAP5.a 195 to 936 2 to 750   capped   747/752
(99 %)
10 diff
(98.7 %id)
BC016276 Lung, small cell carcinoma DLGAP5.a 215 to 2974 1 to 2760 exact available from MGC, AAA   2760/2760
(100 %)
1 diff
(100.0 %id)
TI_1948149467   DLGAP5.a 218 to 915 130 to 829       700/1427
(49 %)
29 diff
(98.0 %id)
BT007344   DLGAP5.a 461 to 2756 1 to 2296       2296/2298
(99 %)
2 diff
(100.0 %id)
AU124964   DLGAP5.a 793 to 1595 2 to 802   capped   801/802
(99 %)
5 diff
(99.4 %id)
TI_1948150394   DLGAP5.a 1770 to 2757 1115 to 127       989/1340
(73 %)
40 diff
(97.1 %id)
TI_1948149507   DLGAP5.a 1858 to 2757 1024 to 124       901/1303
(69 %)
47 diff
(96.4 %id)
TI_1948150395   DLGAP5.a 1858 to 2757 1040 to 129       912/1294
(70 %)
31 diff
(97.7 %id)
TI_1948149506   DLGAP5.a 1862 to 2757 1017 to 119       899/1380
(65 %)
31 diff
(97.8 %id)
TI_1948149802   DLGAP5.a 1862 to 2757 1009 to 119       891/1332
(66 %)
33 diff
(97.6 %id)
TI_1948150350   DLGAP5.a 1862 to 2757 1028 to 130       899/1297
(69 %)
15 diff
(98.9 %id)
TI_1948149760   DLGAP5.a 1864 to 2757 1022 to 124       899/1317
(68 %)
29 diff
(97.8 %id)
TI_1948149803   DLGAP5.a 1864 to 2757 1025 to 131       895/1292
(69 %)
29 diff
(97.8 %id)
TI_1948150094   DLGAP5.a 1872 to 2757 1012 to 128       885/1324
(66 %)
7 diff
(99.5 %id)
BX463083 fetal liver, Liver DLGAP5.a 1881 to 2850 1 to 966       966/992
(97 %)
12 diff
(98.8 %id)
TI_1948150053   DLGAP5.a 1888 to 2757 1009 to 131       879/1386
(63 %)
23 diff
(98.4 %id)
AA262211 germinal center B cell DLGAP5.a 1919 to 2163 1 to 245       245/246
(99 %)
4 diff
(98.4 %id)
TI_1948150095   DLGAP5.a 1936 to 2757 953 to 127       827/1339
(61 %)
27 diff
(98.0 %id)
BG027498 Bone, osteosarcoma, cell line DLGAP5.a 2031 to 2712 1 to 680       680/683
(99 %)
4 diff
(99.5 %id)
TI_1948150054   DLGAP5.a 2074 to 2757 827 to 141       687/1410
(48 %)
24 diff
(98.3 %id)
BM831559 stomach DLGAP5.a 2083 to 2745 1 to 663       663/663
(100 %)
0 diff
(100 %id)
BE748623 bone marrow, from acute myelogenous leukemia DLGAP5.a 2095 to 2917 835 to 13       823/991
(83 %)
14 diff
(98.6 %id)
TI_1948150349   DLGAP5.a 2108 to 2757 781 to 130       652/1446
(45 %)
9 diff
(99.4 %id)
CR622849 T cells (Jurkat cell line) Cot10-normalized DLGAP5.a 2124 to 2975 1 to 852       852/852
(100 %)
0 diff
(100 %id)
BX383299   DLGAP5.a 2124 to 2975 1 to 853       853/853
(100 %)
3 diff
(99.7 %id)
BX388495   DLGAP5.a 2125 to 2961 839 to 3       837/839
(99 %)
3 diff
(99.7 %id)
TI_1948149468   DLGAP5.a 2147 to 2757 750 to 129       620/1380
(44 %)
38 diff
(97.3 %id)
AI671795 pooled germ cell tumors DLGAP5.a 2177 to 2971 803 to 9       795/803
(99 %)
17 diff
(97.9 %id)
N41764 placenta DLGAP5.a 2193 to 2612 1 to 424   fully sequenced,   424/424
(100 %)
9 diff
(97.9 %id)
AW003088 pooled germ cell tumors DLGAP5.a 2218 to 2974 756 to 2       755/759
(99 %)
9 diff
(98.9 %id)
BG290182 bladder, transitional cell papilloma, cell line DLGAP5.a 2229 to 2930 1 to 704       706/704
(100 %)
41 diff
(94.2 %id)
AI591198 brain, tumor, 5 pooled (see description) DLGAP5.a 2240 to 2974 738 to 14   AAA   726/725
(100 %)
31 diff
(95.8 %id)
AU122916   DLGAP5.a 2254 to 2838 2 to 590   capped   589/750
(78 %)
12 diff
(98.4 %id)
AI655814 pooled germ cell tumors DLGAP5.a 2270 to 2974 706 to 5       702/706
(99 %)
7 diff
(99.1 %id)
BG026416 Bone, osteosarcoma, cell line DLGAP5.a 2277 to 2981 1 to 698       698/711
(98 %)
13 diff
(98.2 %id)
BF034910 adenocarcinoma, ovary DLGAP5.a 2296 to 2976 1 to 683       683/686
(99 %)
15 diff
(97.9 %id)
AI174844 Liver DLGAP5.a 2309 to 2997 1 to 691   tiling clone,   691/694
(99 %)
6 diff
(99.2 %id)
BE500979 pooled germ cell tumors DLGAP5.a 2335 to 2974 643 to 5       639/660
(96 %)
10 diff
(98.5 %id)
BF435708 pooled DLGAP5.a 2336 to 2753 417 to 1       417/475
(87 %)
7 diff
(98.6 %id)
AW593825 pooled germ cell tumors DLGAP5.a 2378 to 2974 601 to 5       597/601
(99 %)
11 diff
(98.2 %id)
AU154708   DLGAP5.a 2400 to 2974 573 to 1       573/575
(99 %)
9 diff
(98.5 %id)
BF002428 colon, colon tumor, RER+ DLGAP5.a 2410 to 2959 564 to 15   AAA   550/606
(90 %)
24 diff
(96.1 %id)
AA936879 squamous cell carcinoma from base of tongue, tongue DLGAP5.a 2411 to 2974 569 to 4       566/569
(99 %)
15 diff
(97.4 %id)
AU148722   DLGAP5.a 2420 to 2974 554 to 1       554/556
(99 %)
7 diff
(98.8 %id)
AU143933 whole embryo, mainly head DLGAP5.a 2427 to 2975 541 to 1       541/545
(99 %)
19 diff
(96.6 %id)
AW590532 pooled germ cell tumors DLGAP5.a 2453 to 2974 525 to 4       522/525
(99 %)
3 diff
(99.5 %id)
BE552406 pooled germ cell tumors DLGAP5.a 2480 to 2753 274 to 1       274/274
(100 %)
5 diff
(98.2 %id)
AI004743   DLGAP5.a 2481 to 2974 497 to 4       494/498
(99 %)
6 diff
(98.8 %id)
AI500713 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus DLGAP5.a 2481 to 2974 520 to 27   AAA   494/495
(99 %)
4 diff
(99.2 %id)
AA630025 lung, lung carcinoma DLGAP5.a 2488 to 2809 1 to 321     Submitted on the opposite strand 321/321
(100 %)
8 diff
(97.6 %id)
AI095895 uterus DLGAP5.a 2489 to 2974 496 to 11   AAA   486/486
(100 %)
0 diff
(100 %id)
AW768641 lymph node, lymphoma, follicular mixed small and largecell DLGAP5.a 2492 to 2974 486 to 4       483/486
(99 %)
12 diff
(97.6 %id)
DB517561 testis DLGAP5.a 2516 to 2974 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
BF059746 pooled germ cell tumors DLGAP5.a 2520 to 2974 455 to 1       455/455
(100 %)
2 diff
(99.6 %id)
AW236596 pooled germ cell tumors DLGAP5.a 2525 to 2974 451 to 2       450/451
(99 %)
0 diff
(100 %id)
AW593938 pooled germ cell tumors DLGAP5.a 2525 to 2974 451 to 2       450/451
(99 %)
0 diff
(100 %id)
AW594030 pooled germ cell tumors DLGAP5.a 2527 to 2974 449 to 2       448/451
(99 %)
0 diff
(100 %id)
DB525655 testis DLGAP5.a 2541 to 2974 1 to 434     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
DB517137 testis DLGAP5.a 2542 to 2972 1 to 431     Submitted on the opposite strand 431/433
(99 %)
1 diff
(99.8 %id)
DB515519 testis DLGAP5.a 2543 to 2974 1 to 432     Submitted on the opposite strand 432/432
(100 %)
1 diff
(99.8 %id)
DB513533 testis DLGAP5.a 2547 to 2972 1 to 428     Submitted on the opposite strand 428/430
(99 %)
6 diff
(98.7 %id)
N32765 placenta DLGAP5.a 2555 to 2974 421 to 1   fully sequenced,   421/421
(100 %)
3 diff
(99.3 %id)
DB512056 testis DLGAP5.a 2565 to 2972 1 to 409     Submitted on the opposite strand 409/411
(99 %)
4 diff
(99.1 %id)
AA314540 colon DLGAP5.a 2582 to 2933 351 to 1     Submitted on the opposite strand 351/356
(98 %)
2 diff
(99.5 %id)
AA897234 pooled DLGAP5.a 2582 to 2974 397 to 5       393/397
(98 %)
0 diff
(100 %id)
AA262212 germinal center B cell DLGAP5.a 2588 to 2974 389 to 4       386/389
(99 %)
0 diff
(100 %id)
NM_001146015.1   DLGAP5.b 1 to 3084 1 to 3084 exact RefSeq,   3084/3084
(100 %)
0 diff
(100 %id)
BJ991150 hepatoblastoma DLGAP5.b 59 to 641 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BM788630 stomach DLGAP5.b 59 to 671 1 to 613   tiling clone,   613/613
(100 %)
0 diff
(100 %id)
DA904334   DLGAP5.b 61 to 327 2 to 270   capped   269/269
(100 %)
6 diff
(97.8 %id)
DB090294 testis DLGAP5.b 61 to 637 2 to 579   capped   578/578
(100 %)
7 diff
(98.8 %id)
DA661384   DLGAP5.b 62 to 623 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DB078848 testis DLGAP5.b 62 to 622 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DB100792 testis DLGAP5.b 62 to 651 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DB090607 testis DLGAP5.b 63 to 638 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BU568362 testis DLGAP5.b 64 to 652 1 to 580       580/771
(75 %)
49 diff
(93.7 %id)
DB094409 testis DLGAP5.b 64 to 614 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA496139 brain DLGAP5.b 66 to 607 9 to 550   capped   542/542
(100 %)
0 diff
(100 %id)
DA905562   DLGAP5.b 66 to 622 9 to 565   capped   557/557
(100 %)
0 diff
(100 %id)
BX951337   DLGAP5.b 67 to 675 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
DA451787 tongue, tumor tissue DLGAP5.b 72 to 652 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BP356588 mammary gland DLGAP5.b 74 to 650 1 to 577       577/582
(99 %)
5 diff
(99.2 %id)
DA600676   DLGAP5.b 75 to 617 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB089270 testis DLGAP5.b 75 to 625 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB081761 testis DLGAP5.b 82 to 631 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB452029 testis DLGAP5.b 84 to 583 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BJ992200 hepatoblastoma DLGAP5.b 84 to 683 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BU660430 blood DLGAP5.b 85 to 539 7 to 461       455/461
(98 %)
8 diff
(98.3 %id)
BX490237   DLGAP5.b 85 to 606 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
DA508378 brain DLGAP5.b 85 to 662 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA753435   DLGAP5.b 85 to 621 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DA902151   DLGAP5.b 85 to 662 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DB055581 testis DLGAP5.b 85 to 666 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DB122901 thymus DLGAP5.b 85 to 650 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB199118 trachea DLGAP5.b 85 to 638 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
BX474995   DLGAP5.b 86 to 672 1 to 588       588/588
(100 %)
5 diff
(99.2 %id)
DA658731   DLGAP5.b 87 to 650 2 to 565   capped   564/567
(99 %)
2 diff
(99.7 %id)
DA739362   DLGAP5.b 87 to 635 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB074412 testis DLGAP5.b 87 to 630 2 to 547   capped   546/546
(100 %)
4 diff
(99.3 %id)
DB127970 thymus DLGAP5.b 87 to 649 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DB129560 thymus DLGAP5.b 87 to 623 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
BX496200 Liver DLGAP5.b 88 to 729 1 to 642       642/642
(100 %)
2 diff
(99.7 %id)
BX495872 Liver DLGAP5.b 88 to 610 1 to 523       523/523
(100 %)
2 diff
(99.7 %id)
BX494656 Liver DLGAP5.b 88 to 316 1 to 230       230/230
(100 %)
3 diff
(98.7 %id)
DB450019 testis DLGAP5.b 88 to 569 1 to 486       486/486
(100 %)
8 diff
(98.4 %id)
BG612911 embryonal carcinoma, testis DLGAP5.b 88 to 793 1 to 710       710/715
(99 %)
6 diff
(99.2 %id)
BM764029 myeloma DLGAP5.b 88 to 641 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
DA472264   DLGAP5.b 90 to 639 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA473488   DLGAP5.b 90 to 639 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
AL710891 human skeletal muscle DLGAP5.b 90 to 920 1 to 828       828/837
(98 %)
7 diff
(99.2 %id)
DA549704   DLGAP5.b 90 to 666 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA843700 placenta DLGAP5.b 90 to 649 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BU561098 testis DLGAP5.b 91 to 656 1 to 568       568/798
(71 %)
12 diff
(98.5 %id)
BP225229   DLGAP5.b 93 to 668 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
DB153380 thymus DLGAP5.b 93 to 681 2 to 591   capped   590/590
(100 %)
3 diff
(99.5 %id)
DA476026   DLGAP5.b 94 to 666 2 to 575   capped   574/574
(100 %)
4 diff
(99.4 %id)
BP239557 Liver DLGAP5.b 94 to 706 1 to 613       613/613
(100 %)
2 diff
(99.7 %id)
BP313468 mammary gland DLGAP5.b 94 to 674 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM751898 Ascites, stomach DLGAP5.b 94 to 665 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
DA003954   DLGAP5.b 95 to 668 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BP871449 embryonal kidney DLGAP5.b 95 to 425 1 to 331       331/331
(100 %)
0 diff
(100 %id)
DA025912   DLGAP5.b 95 to 661 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA031112   DLGAP5.b 95 to 657 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA434047 tongue, tumor tissue DLGAP5.b 95 to 632 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA441224 tongue, tumor tissue DLGAP5.b 95 to 679 2 to 587   capped   586/593
(98 %)
2 diff
(99.7 %id)
DA476750   DLGAP5.b 95 to 635 2 to 544   capped   543/543
(100 %)
4 diff
(99.3 %id)
DA477056   DLGAP5.b 95 to 650 2 to 557   capped   556/559
(99 %)
1 diff
(99.9 %id)
DA480499   DLGAP5.b 95 to 641 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA643461   DLGAP5.b 95 to 647 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA643462   DLGAP5.b 95 to 640 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA657528   DLGAP5.b 95 to 649 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA661795   DLGAP5.b 95 to 670 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA905734   DLGAP5.b 95 to 648 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA948541 Spleen DLGAP5.b 95 to 638 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB090093 testis DLGAP5.b 95 to 663 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB114893 thymus DLGAP5.b 95 to 388 2 to 295   capped   294/294
(100 %)
0 diff
(100 %id)
DB119228 thymus DLGAP5.b 95 to 660 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB124771 thymus DLGAP5.b 95 to 637 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB142573 thymus DLGAP5.b 95 to 625 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
DB145063 thymus DLGAP5.b 95 to 603 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DB150287 thymus DLGAP5.b 95 to 659 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB150558 thymus DLGAP5.b 95 to 655 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB152063 thymus DLGAP5.b 95 to 629 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DB155084 thymus DLGAP5.b 95 to 428 2 to 335   capped   334/339
(98 %)
1 diff
(99.8 %id)
DB165517 thymus DLGAP5.b 95 to 699 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DB128490 thymus DLGAP5.b 96 to 604 2 to 513   capped   512/512
(100 %)
3 diff
(99.5 %id)
BX498565 Liver DLGAP5.b 98 to 603 1 to 506       506/506
(100 %)
8 diff
(98.5 %id)
DA499373 brain DLGAP5.b 98 to 678 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA818709   DLGAP5.b 98 to 656 2 to 561   capped   560/562
(99 %)
6 diff
(99.0 %id)
BX496329 Liver DLGAP5.b 99 to 614 1 to 516       516/516
(100 %)
2 diff
(99.7 %id)
BG776934 lung, mucoepidermoid carcinoma DLGAP5.b 99 to 794 1 to 699       699/724
(96 %)
16 diff
(97.8 %id)
CN306955 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells DLGAP5.b 100 to 494 1 to 397       397/397
(100 %)
4 diff
(99.0 %id)
DB460215 testis DLGAP5.b 100 to 558 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BP238494 Liver DLGAP5.b 100 to 650 1 to 551       551/612
(90 %)
3 diff
(99.6 %id)
BP249518 Kidney DLGAP5.b 100 to 682 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA741663   DLGAP5.b 100 to 429 2 to 333   capped   332/332
(100 %)
5 diff
(98.5 %id)
DA028709   DLGAP5.b 101 to 580 2 to 481   capped   480/480
(100 %)
1 diff
(99.8 %id)
BX490327   DLGAP5.b 101 to 689 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
BP235041 coronary artery DLGAP5.b 101 to 683 1 to 583       583/583
(100 %)
11 diff
(98.2 %id)
DA741665   DLGAP5.b 101 to 581 2 to 487   capped   486/486
(100 %)
8 diff
(98.4 %id)
DA814537   DLGAP5.b 101 to 655 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA886288   DLGAP5.b 101 to 647 2 to 548   capped   547/547
(100 %)
3 diff
(99.5 %id)
DA902773   DLGAP5.b 101 to 663 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA905610   DLGAP5.b 101 to 636 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DA985480 synovial membrane tissue from rheumatioidarthritis DLGAP5.b 101 to 652 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DB029445 testis DLGAP5.b 101 to 674 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DB150879 thymus DLGAP5.b 101 to 621 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
DA474204   DLGAP5.b 102 to 666 2 to 567   capped   566/566
(100 %)
7 diff
(98.8 %id)
DA655810   DLGAP5.b 102 to 666 2 to 565   capped   564/565
(99 %)
4 diff
(99.3 %id)
DA902971   DLGAP5.b 102 to 664 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DB149360 thymus DLGAP5.b 102 to 582 2 to 483   capped   482/482
(100 %)
2 diff
(99.6 %id)
DA023235   DLGAP5.b 103 to 675 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA996468   DLGAP5.b 103 to 638 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DB146446 thymus DLGAP5.b 103 to 582 2 to 482   capped   481/481
(100 %)
3 diff
(99.4 %id)
CN306948 embryonic stem cells, cell lines H1, H7, andH9 DLGAP5.b 106 to 403 19 to 316       298/316
(94 %)
6 diff
(98.2 %id)
AL702240 human skeletal muscle DLGAP5.b 106 to 630 1 to 525       525/525
(100 %)
4 diff
(99.3 %id)
BX951004   DLGAP5.b 106 to 768 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
BE960916 melanotic melanoma, high MDR, skin DLGAP5.b 106 to 626 1 to 511       511/514
(99 %)
11 diff
(97.9 %id)
DN996461 breast cancer, Mammary gland (cancer tissue) DLGAP5.b 107 to 853 1 to 747       747/747
(100 %)
4 diff
(99.5 %id)
BU664187 blood DLGAP5.b 109 to 754 1 to 645       645/645
(100 %)
7 diff
(99.0 %id)
BQ213788 embryonal carcinoma, cell line, testis DLGAP5.b 109 to 1009 1 to 899       899/899
(100 %)
7 diff
(99.3 %id)
CN306950 embryonic stem cells, cell lines H1, H7, andH9 DLGAP5.b 112 to 780 12 to 680       669/680
(98 %)
6 diff
(99.2 %id)
DR159574 human embryonic stem cells differentiated toan early endodermal cell type DLGAP5.b 114 to 900 1 to 787       787/787
(100 %)
0 diff
(100 %id)
BE781994 eye, retinoblastoma DLGAP5.b 115 to 767 1 to 667       667/961
(69 %)
33 diff
(96.6 %id)
BG531552 embryonal carcinoma, testis DLGAP5.b 117 to 786 1 to 675       675/791
(85 %)
14 diff
(98.3 %id)
CA454937   DLGAP5.b 117 to 992 1 to 878       878/897
(97 %)
6 diff
(99.4 %id)
DA473069   DLGAP5.b 123 to 691 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
AL701760 human skeletal muscle DLGAP5.b 123 to 675 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
DB054215 testis DLGAP5.b 123 to 687 2 to 569   capped   568/568
(100 %)
5 diff
(99.2 %id)
AK299338   DLGAP5.b 124 to 3065 1 to 2942 M328T     2942/2942
(100 %)
1 diff
(100.0 %id)
DA479909   DLGAP5.b 125 to 691 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA758269   DLGAP5.b 125 to 670 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA888623   DLGAP5.b 125 to 682 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
CN306943 embryonic stem cells, cell lines H1, H7, andH9 DLGAP5.b 126 to 867 1 to 742       742/742
(100 %)
1 diff
(99.9 %id)
CN306946 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells DLGAP5.b 126 to 890 1 to 767       767/771
(99 %)
5 diff
(99.4 %id)
CN306954 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 DLGAP5.b 126 to 771 1 to 647       647/647
(100 %)
2 diff
(99.7 %id)
AU135764 placenta DLGAP5.b 128 to 896 2 to 768   capped   767/771
(99 %)
11 diff
(98.6 %id)
BP365066 lung DLGAP5.b 128 to 709 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB134070 thymus DLGAP5.b 129 to 679 2 to 553   capped   552/554
(99 %)
2 diff
(99.7 %id)
BM549481 melanotic melanoma, skin DLGAP5.b 130 to 802 9 to 686       678/864
(78 %)
22 diff
(97.5 %id)
CN306949 embryonic stem cells, cell lines H1, H7, andH9 DLGAP5.b 133 to 265 1 to 133       133/133
(100 %)
1 diff
(99.3 %id)
BQ219261 melanotic melanoma, skin DLGAP5.b 134 to 701 11 to 582       572/1054
(54 %)
28 diff
(97.4 %id)
BX248255 T cells (Jurkat cell line) DLGAP5.b 135 to 2852 1 to 2718 exact tiling clone,   2718/2718
(100 %)
0 diff
(100 %id)
BX443382 T cells (Jurkat cell line) DLGAP5.b 135 to 1158 1 to 1021       1021/1021
(100 %)
11 diff
(99.0 %id)
BX450059 T cells (Jurkat cell line) DLGAP5.b 135 to 1118 1 to 984       984/984
(100 %)
1 diff
(99.9 %id)
BM466656 eye, retinoblastoma DLGAP5.b 138 to 992 7 to 862       856/1073
(79 %)
15 diff
(98.7 %id)
AA312033   DLGAP5.b 161 to 561 1 to 403       403/404
(99 %)
4 diff
(99.1 %id)
CN306944 embryonic stem cells, cell lines H1, H7, andH9 DLGAP5.b 166 to 399 1 to 233       233/233
(100 %)
1 diff
(99.6 %id)
CN306953 embryonic stem cells, DMSO-treated H9 cellline DLGAP5.b 176 to 741 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
BE263782 lung, small cell carcinoma DLGAP5.b 211 to 849 1 to 635       636/636
(100 %)
9 diff
(98.6 %id)
CV025366 mixed DLGAP5.b 218 to 876 1 to 659       659/659
(100 %)
2 diff
(99.7 %id)
CV027659 mixed DLGAP5.b 218 to 833 1 to 616       616/616
(100 %)
4 diff
(99.4 %id)
TI_1948149504   DLGAP5.b 218 to 1194 136 to 1108       973/1396
(69 %)
41 diff
(97.1 %id)
TI_1948149505   DLGAP5.b 218 to 919 126 to 832       708/1424
(49 %)
18 diff
(98.8 %id)
TI_1948149800   DLGAP5.b 218 to 1268 134 to 1182       1049/1400
(74 %)
67 diff
(95.3 %id)
TI_1948149801   DLGAP5.b 218 to 927 133 to 844       712/1459
(48 %)
20 diff
(98.7 %id)
TI_1948150051   DLGAP5.b 218 to 1197 134 to 1120       987/1481
(66 %)
37 diff
(97.6 %id)
TI_1948150052   DLGAP5.b 218 to 1137 130 to 1048       918/1389
(66 %)
37 diff
(97.4 %id)
TI_1948150092   DLGAP5.b 218 to 1271 130 to 1188       1059/1425
(74 %)
53 diff
(96.3 %id)
TI_1948150093   DLGAP5.b 218 to 1280 128 to 1191       1064/1446
(73 %)
55 diff
(96.2 %id)
TI_1948150347   DLGAP5.b 218 to 1266 134 to 1164       1031/1408
(73 %)
53 diff
(96.3 %id)
TI_1948150392   DLGAP5.b 218 to 1274 130 to 1199       1068/1459
(73 %)
63 diff
(95.7 %id)
TI_1948150393   DLGAP5.b 218 to 1163 127 to 1073       947/1465
(64 %)
35 diff
(97.7 %id)
CD644234 Embryonic Stem cells DLGAP5.b 246 to 994 1 to 740       740/809
(91 %)
12 diff
(98.6 %id)
DA998159   DLGAP5.b 261 to 820 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
AU129454   DLGAP5.b 315 to 928 2 to 616   capped   615/639
(96 %)
9 diff
(98.6 %id)
DB101932 thymus DLGAP5.b 320 to 879 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CN306945 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells DLGAP5.b 348 to 626 1 to 279       279/279
(100 %)
1 diff
(99.7 %id)
BM827600 stomach DLGAP5.b 362 to 930 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM723156 eye, fetal eye DLGAP5.b 368 to 973 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BF698666 brain, primitive neuroectoderm DLGAP5.b 434 to 1116 1 to 680       680/871
(78 %)
18 diff
(98.0 %id)
BP871216 embryonal kidney DLGAP5.b 481 to 814 1 to 332       332/332
(100 %)
5 diff
(98.5 %id)
AW505002 lymph DLGAP5.b 486 to 957 1 to 472       472/472
(100 %)
7 diff
(98.6 %id)
TI_154161430   DLGAP5.b 493 to 1071 76 to 654       579/579
(100 %)
14 diff
(97.6 %id)
CX785433 human embryonic stem cells DLGAP5.b 501 to 1387 1 to 887       887/887
(100 %)
3 diff
(99.7 %id)
CX165495 human embryonic stem cells differentiated toan early endodermal cell type DLGAP5.b 584 to 1442 1 to 859       859/859
(100 %)
0 diff
(100 %id)
N56381   DLGAP5.b 630 to 795 1 to 166       166/182
(91 %)
3 diff
(98.4 %id)
CX785562 human embryonic stem cells DLGAP5.b 652 to 1468 1 to 817       817/817
(100 %)
0 diff
(100 %id)
AU124104   DLGAP5.b 663 to 1461 2 to 800   capped   799/803
(99 %)
6 diff
(99.3 %id)
CN306947 embryonic stem cells, DMSO-treated H9 cellline DLGAP5.b 684 to 1450 1 to 767       767/767
(100 %)
5 diff
(99.4 %id)
BE890401 melanotic melanoma, skin DLGAP5.b 695 to 1487 1 to 797       797/1017
(78 %)
18 diff
(98.3 %id)
BF701248 brain, primitive neuroectoderm DLGAP5.b 754 to 1389 1 to 635       635/847
(74 %)
9 diff
(99.0 %id)
BG402889 bladder, transitional cell papilloma, cell line DLGAP5.b 768 to 1609 1 to 838       840/997
(84 %)
38 diff
(96.2 %id)
BX408914 T cells (Jurkat cell line) DLGAP5.b 810 to 1604 1 to 797       797/865
(92 %)
26 diff
(97.0 %id)
BQ422141 large cell carcinoma, lung DLGAP5.b 812 to 1589 1 to 780       780/845
(92 %)
9 diff
(99.0 %id)
DB038781 testis DLGAP5.b 823 to 1401 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BM839127 Ascites, stomach DLGAP5.b 824 to 1342 1 to 518       518/518
(100 %)
3 diff
(99.5 %id)
AL708268 human skeletal muscle DLGAP5.b 870 to 1523 1 to 654       654/654
(100 %)
0 diff
(100 %id)
BG615468 embryonal carcinoma, testis DLGAP5.b 875 to 1692 1 to 811       811/818
(99 %)
17 diff
(98.0 %id)
BU508327 leiomyosarcoma, uterus DLGAP5.b 900 to 1515 1 to 629       629/1214
(51 %)
29 diff
(97.7 %id)
AW855498 colon DLGAP5.b 920 to 1219 71 to 370       299/370
(80 %)
6 diff
(98.4 %id)
BX452296 T cells (Jurkat cell line) DLGAP5.b 990 to 1779 1 to 789       789/789
(100 %)
2 diff
(99.8 %id)
CD644577 Embryonic Stem cells DLGAP5.b 1013 to 1762 1 to 750       750/845
(88 %)
9 diff
(99.0 %id)
BE814258 breast_normal DLGAP5.b 1115 to 1383 3 to 270       268/270
(99 %)
10 diff
(96.3 %id)
BF209525 bone marrow, from chronic myelogenous leukemia DLGAP5.b 1120 to 1668 1 to 558       560/811
(69 %)
44 diff
(94.6 %id)
BI087140 cervix DLGAP5.b 1126 to 1938 1 to 817       817/818
(99 %)
19 diff
(97.7 %id)
Z21439   DLGAP5.b 1187 to 1518 1 to 330       330/332
(99 %)
3 diff
(99.1 %id)
BX433266 T cells (Jurkat cell line) DLGAP5.b 1198 to 2009 814 to 1       814/837
(97 %)
30 diff
(96.5 %id)
Z21216   DLGAP5.b 1200 to 1477 1 to 277       277/277
(100 %)
1 diff
(99.7 %id)
CA488299   DLGAP5.b 1258 to 2125 1 to 869       869/869
(100 %)
2 diff
(99.8 %id)
CB112147 Liver DLGAP5.b 1267 to 1763 1 to 497       497/497
(100 %)
0 diff
(100 %id)
CN306952 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 DLGAP5.b 1324 to 1881 10 to 567       558/567
(98 %)
6 diff
(99.0 %id)
AA258708 germinal center B cell DLGAP5.b 1339 to 1518 1 to 181       181/184
(98 %)
6 diff
(96.8 %id)
BX103023 heart DLGAP5.b 1361 to 2130 1 to 772       772/772
(100 %)
2 diff
(99.8 %id)
W93568 heart DLGAP5.b 1361 to 1748 1 to 394       394/399
(98 %)
9 diff
(97.8 %id)
BP267088 thyroid DLGAP5.b 1397 to 1958 1 to 557       557/557
(100 %)
3 diff
(99.5 %id)
BP266672 thyroid DLGAP5.b 1398 to 1983 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP266688 thyroid DLGAP5.b 1398 to 1982 1 to 580       580/580
(100 %)
5 diff
(99.2 %id)
CN306942 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 DLGAP5.b 1420 to 1835 1 to 416       416/418
(99 %)
5 diff
(98.9 %id)
FN097482 breast carcinoma DLGAP5.b 1459 to 1510 1 to 51       51/52
(98 %)
2 diff
(96.2 %id)
BG291803 bladder, transitional cell papilloma, cell line DLGAP5.b 1599 to 2168 1 to 578       578/720
(80 %)
20 diff
(97.3 %id)
BE748075 bone marrow, from acute myelogenous leukemia DLGAP5.b 1608 to 2253 1 to 639       639/849
(75 %)
11 diff
(98.8 %id)
BM788687 stomach DLGAP5.b 1622 to 2059 1 to 438       438/438
(100 %)
0 diff
(100 %id)
BG574350 breast, mammary adenocarcinoma, cell line DLGAP5.b 1651 to 2387 1 to 735       735/736
(99 %)
7 diff
(99.1 %id)
DN915327   DLGAP5.b 1652 to 2311 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
AA250863 germinal center B cell DLGAP5.b 1677 to 2153 1 to 476       476/476
(100 %)
2 diff
(99.6 %id)
BG032642 breast, mammary adenocarcinoma, cell line DLGAP5.b 1721 to 2437 29 to 745       717/993
(72 %)
23 diff
(97.7 %id)
AA311151   DLGAP5.b 1739 to 2185 1 to 447       447/447
(100 %)
1 diff
(99.8 %id)
AW966682   DLGAP5.b 1740 to 2280 1 to 543       543/561
(96 %)
22 diff
(96.1 %id)
BX450058 T cells (Jurkat cell line) DLGAP5.b 1839 to 2868 1033 to 1       1033/1033
(100 %)
19 diff
(98.2 %id)
CB129479 Liver DLGAP5.b 1842 to 2309 1 to 468       468/468
(100 %)
0 diff
(100 %id)
BF339048 brain, glioblastoma with EGFR amplification DLGAP5.b 1862 to 2585 23 to 746       724/817
(88 %)
25 diff
(97.0 %id)
BJ991151 hepatoblastoma DLGAP5.b 1877 to 2416 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BF184465 bone marrow, from chronic myelogenous leukemia DLGAP5.b 1884 to 2579 1 to 705       705/845
(83 %)
37 diff
(95.7 %id)
BF244166 brain, glioblastoma DLGAP5.b 1891 to 2503 1 to 613       613/614
(99 %)
5 diff
(99.2 %id)
DN915328   DLGAP5.b 1961 to 2322 363 to 1       363/373
(97 %)
16 diff
(95.8 %id)
W93717 heart DLGAP5.b 1984 to 2438 459 to 1       459/468
(98 %)
7 diff
(98.6 %id)
AU156266 placenta DLGAP5.b 2050 to 2437 390 to 1       390/392
(99 %)
9 diff
(97.8 %id)
Z21217   DLGAP5.b 2076 to 2414 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
BE245871 leukopheresis DLGAP5.b 2085 to 2437 353 to 1       353/353
(100 %)
3 diff
(99.2 %id)
W25701 lung DLGAP5.b 2089 to 2409 1 to 321       321/321
(100 %)
2 diff
(99.4 %id)
BM772338 stomach DLGAP5.b 2128 to 2802 1 to 677       675/677
(99 %)
0 diff
(100 %id)
Z21438   DLGAP5.b 2146 to 2415 268 to 1       268/268
(100 %)
7 diff
(97.4 %id)
AW386194 pnet DLGAP5.b 2284 to 2512 229 to 1       229/232
(98 %)
1 diff
(99.6 %id)
AW394284 pnet DLGAP5.b 2284 to 2512 229 to 1       229/232
(98 %)
1 diff
(99.6 %id)
TI_154126409   DLGAP5.b 2341 to 3065 803 to 81   AAA   723/960
(75 %)
6 diff
(99.4 %id)
CA416481 Chondrosarcoma Cell line DLGAP5.b 2341 to 3065 741 to 19   AAA   723/782
(92 %)
6 diff
(99.3 %id)
BQ014921 Chondrosarcoma, Left Pubic Bone DLGAP5.b 2359 to 3065 725 to 19   AAA   707/707
(100 %)
3 diff
(99.6 %id)
AI961694 thymus, pooled DLGAP5.b 2402 to 3065 673 to 8       664/673
(98 %)
14 diff
(98.0 %id)
BU630671 cell lines, Chondrosarcoma DLGAP5.b 2406 to 3066 681 to 19   AAA   663/663
(100 %)
2 diff
(99.7 %id)
EC482853 Prostate DLGAP5.b 2449 to 2548 1 to 95       95/95
(100 %)
7 diff
(92.7 %id)
AU151565   DLGAP5.b 2575 to 3088 513 to 1   tiling clone,   513/573
(89 %)
8 diff
(98.7 %id)
AW235220 pooled germ cell tumors DLGAP5.b 2727 to 3072 354 to 9   tiling clone,   346/371
(93 %)
5 diff
(98.7 %id)
AW235277 pooled germ cell tumors DLGAP5.b 2727 to 3065 354 to 16       339/381
(88 %)
0 diff
(100 %id)
AI524747 serous papillary carcinoma, high grade, 2pooled tumors, uterus DLGAP5.b 2728 to 3066 350 to 13   AAA   338/362
(93 %)
13 diff
(96.5 %id)
BM677677 eye, fetal eye DLGAP5.b 2731 to 2884 173 to 19   AAA   155/160
(96 %)
1 diff
(99.4 %id)
AA250864 germinal center B cell DLGAP5.b 2757 to 3065 318 to 10       309/318
(97 %)
0 diff
(100 %id)
BX330869   DLGAP5.b 2763 to 3064 307 to 1       307/342
(89 %)
17 diff
(95.1 %id)
BX347017   DLGAP5.b 2798 to 3066 1 to 269       269/269
(100 %)
2 diff
(99.3 %id)
F13761   DLGAP5.b 2806 to 3070 273 to 11   tiling clone, AAA   263/263
(100 %)
2 diff
(99.3 %id)
BX326370   DLGAP5.b 2845 to 3066 1 to 223       223/223
(100 %)
1 diff
(99.6 %id)
AU130418   DLGAP5.c 1 to 872 4 to 882   tiling clone, capped   878/881
(99 %)
12 diff
(98.7 %id)
DB367617   DLGAP5.c 2182 to 2724 542 to 1   tiling clone,   542/544
(99 %)
5 diff
(99.1 %id)
DR759954 embryonic stem DLGAP5.c 2449 to 3004 1 to 556   tiling clone,   556/556
(100 %)
0 diff
(100 %id)
BP284586 bone marrow DLGAP5.d 1 to 587 2 to 588   tiling clone,   588/588
(100 %)
0 diff
(100 %id)
DA644858   DLGAP5.d 16 to 597 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BP240200 Liver DLGAP5.d 18 to 596 1 to 579       579/579
(100 %)
5 diff
(99.2 %id)
DA453020 tongue, tumor tissue DLGAP5.d 52 to 623 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB160237 thymus DLGAP5.d 69 to 640 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CD557655 testis DLGAP5.d 150 to 956 30 to 841 A157G K158Q D159R Q160P M161K ... tiling clone,   812/1001
(81 %)
20 diff
(98.1 %id)
BG113791 Bone, osteosarcoma, cell line DLGAP5.e 1 to 521 1 to 522 L47C L49* tiling clone,   752/789
(95 %)
23 diff
(97.1 %id)
BE540046 cervix DLGAP5.f 1 to 686 1 to 698 C22A F23S E24S W25G D26T ... tiling clone,   698/835
(83 %)
42 diff
(95.0 %id)
DB446907 testis DLGAP5.g-u 1 to 318 1 to 317   tiling clone,   317/386
(82 %)
8 diff
(98.0 %id)
DB448424 testis DLGAP5.g-u 1 to 426 1 to 430 R15P A16S L17S E19G I20D ... tiling clone,   430/430
(100 %)
6 diff
(98.7 %id)
DB451654 testis DLGAP5.g-u 1 to 494 1 to 495 A13P L14C R15E A16L L17W ... tiling clone,   495/495
(100 %)
4 diff
(99.2 %id)
AA331648 Embryo, 8 weeks DLGAP5.g-u 361 to 666 1 to 311   tiling clone,   311/311
(100 %)
8 diff
(97.5 %id)
CB128247 Liver DLGAP5.h-u 1 to 426 1 to 425   tiling clone,   425/425
(100 %)
1 diff
(99.8 %id)
BG503831 embryonal carcinoma, testis DLGAP5.h-u 260 to 997 1 to 732 exact tiling clone,   732/789
(92 %)
28 diff
(96.5 %id)
DA417002 thalamus DLGAP5.i-u 1 to 537 2 to 540   tiling clone, capped   539/539
(100 %)
2 diff
(99.7 %id)
AK297480 brain Gene DLGAP5, variant not shown         Suspected internal deletion, this clone was ignored    
CN306951 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 Gene DLGAP5, variant not shown         This clone was ignored    
DC352186 brain Gene DLGAP5, variant not shown         Suspected internal deletion, this clone was ignored    
AI673084 thymus, pooled Gene DLGAP5, variant not shown         Suspected internal deletion, this clone was ignored    
BP271303 small intestine Gene DLGAP5, variant not shown         Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
DA795131 brain Gene DLGAP5, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI